Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Diagnostic tests and headache misdiagnoses in individuals with resistant and refractory migraine - data from the REFINE study.

Cephalalgia : an international journal of headache·2026

Same author

Over 600 million people aged 18-65 will have headache tomorrow: global 1-day prevalence and recall bias from a meta-analysis of individual participant data (N = 38,512) from the general populations of 15 countries.

The journal of headache and pain·2026

Same author

MIDAS and HIT-6 Questionnaires Versus Headache Diaries for Monitoring Treatment Response to Erenumab in Migraine: A REFORM Study.

European journal of neurology·2026

Same author

Public Health.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Same author

The prevalence of headache disorders among children and adolescents in Georgia: a cross-sectional schools-based study.

The journal of headache and pain·2025

Same author

Migraine-related disability according to headache frequency subclassifications: A systematic review and meta-analysis.

Cephalalgia : an international journal of headache·2025

Same journal

An overview of the safety and efficacy of sphenopalatine ganglion stimulation for the treatment of chronic cluster headache.

Expert review of neurotherapeutics·2026

Same journal

Multiomics and proteomic insights into Alzheimer's disease biology in Down syndrome.

Expert review of neurotherapeutics·2026

Same journal

Remote deep brain stimulation programming in childhood dystonia: opportunities, challenges, and future directions.

Expert review of neurotherapeutics·2026

Same journal

The differential diagnosis of astrocytic neoplasms and its impact on treatment and prognosis.

Expert review of neurotherapeutics·2026

Same journal

Corticosteroids in withdrawal therapy following medication-overuse headache: a systematic review.

Expert review of neurotherapeutics·2026

Same journal

Clinical efficacy of lacosamide in neuropathic pain: a systematic review of randomized controlled trials.

Expert review of neurotherapeutics·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 25, 2026

$Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain$

Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain

Published on: May 10, 2017

Update on trigeminal neuralgia.

Mark Obermann¹, Zaza Katsarava

¹Department of Neurology, University of Duisburg-Essen, Essen, Germany. mark.obermann@uni-due.de

Expert Review of Neurotherapeutics

|March 11, 2009

Summary

This summary is machine-generated.

Trigeminal neuralgia causes severe facial pain, affecting women more than men. While treatments exist, research continues to improve understanding and therapies for this condition.

More Related Videos

Microvascular Decompression: Salient Surgical Principles and Technical Nuances

Microvascular Decompression: Salient Surgical Principles and Technical Nuances

Published on: July 5, 2011

Related Experiment Videos

Last Updated: Jun 25, 2026

$Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain$

Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain

Published on: May 10, 2017

Microvascular Decompression: Salient Surgical Principles and Technical Nuances

Microvascular Decompression: Salient Surgical Principles and Technical Nuances

Published on: July 5, 2011

Area of Science:

Neurology
Pain Medicine

Background:

Trigeminal neuralgia is characterized by severe, episodic facial pain.
A constant dull background pain may persist in some patients.
The exact etiology and pathophysiology remain uncertain.

Purpose of the Study:

To summarize the current understanding of trigeminal neuralgia.
To review available medical and surgical treatment options.
To highlight the need for further research.

Main Methods:

Review of existing literature on trigeminal neuralgia.
Analysis of incidence rates and demographic data.
Summary of current treatment modalities and their efficacy.

Main Results:

Incidence is 4.3 per 100,000 person-years, higher in women.
Anticonvulsants, muscle relaxants, and neuroleptics are primary medical treatments.
Surgical options include Gasserian ganglion techniques, gamma-knife surgery, and microvascular decompression for refractory cases.

Conclusions:

Trigeminal neuralgia presents a significant clinical challenge due to uncertain etiology.
Medical management is the first line of treatment, with surgical interventions for resistant cases.
Ongoing research is crucial for advancing the understanding and treatment of trigeminal neuralgia.